James V Caruso insider trades

Open-market stock purchases and sales by James V Caruso, President & CEO at Cellectar Biosciences, Inc, from SEC Form 4 filings since Feb 22, 2010.

Track record: 0% of 7 scored buys are up 5% or more since purchase, averaging -22%.

Recent trades

DateStockTradeValue
Jul 7, 2026CLRB Cellectar Biosciences, IncBought (not open market)—
May 7, 2026CLRB Cellectar Biosciences, IncBought$25K
May 7, 2026CLRB Cellectar Biosciences, IncBought$260

Companies traded

  • CLRB Cellectar Biosciences, Inc: 13 buys, 2 sales, last Jul 7, 2026
  • ALTH Allos Therapeutics Inc: 3 sales, last Mar 1, 2010

Get free alerts when James V Caruso files a new trade →